Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 21, 2017; 23(31): 5764-5772
Published online Aug 21, 2017. doi: 10.3748/wjg.v23.i31.5764
Figure 3
Figure 3 Overall survival of patients according to doublecortin and CaM kinase-like-1 expression. A: The MST of patients with DCLK1-positive tumors was 18.7 mo; B: That of patients with DLCK1-negative tumors was 49.5 mo. The MST of patients with DCLK1 positivity was significantly shorter than that of patients with DCLK1 negativity (P < 0.0001). DCLK1: Doublecortin and CaM kinase-like-1; MST: Median overall survival time.